Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 15/20 | 0.63 |
| ▸ | CYP1A1 | P04798 | 15/20 | 0.63 |
| ▸ | CYP1B1 | Q16678 | 15/20 | 0.63 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.54 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP4B1 | P13584 | 1/20 | 0.54 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.54 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.54 |
| ▸ | CYP2A7 | P20853 | 1/20 | 0.54 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14139624 | 0.94 | CYP1A2 (0.55) | CYP1A2CYP1A1CYP1B1NFE2L2MEN1 | |
| SCHEMBL10069083 | 0.91 | CYP1A2 (0.50) | CYP1A2CYP1A1CYP1B1NFE2L2MEN1 | |
| SCHEMBL10069209 | 0.85 | CYP1A1 (0.58) | CYP1A2CYP1A1CYP1B1NFE2L2MEN1 | |
| SCHEMBL10069213 | 0.85 | MEN1 (0.54) | CYP1A2CYP1A1CYP1B1NFE2L2MEN1 | |
| SCHEMBL10069280 | 0.84 | CYP1A1 (0.56) | CYP1A2CYP1A1CYP1B1NFE2L2MEN1 | |
| SCHEMBL10069081 | 0.84 | CYP1A2 (0.69) | CYP1A2CYP1A1CYP1B1NFE2L2MEN1 | |
| SCHEMBL14434745 | 0.83 | MEN1 (0.63) | CYP1A2CYP1A1CYP1B1NFE2L2MEN1 | |
| SCHEMBL10069216 | 0.82 | CYP1A1 (0.50) | CYP1A2CYP1A1CYP1B1MEN1KMT2A | |
| SCHEMBL25706432 | 0.79 | CYP1A2 (1.00) | CYP1A2CYP1A1CYP1B1NFE2L2MEN1 | |
| SCHEMBL10069736 | 0.78 | MEN1 (0.41) | CYP1A2CYP1A1CYP1B1NFE2L2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124626-B2 | Methods of treating inflammations and infections with pyridinium salts | MYCOSOL, INC. (US) | 2012-02-28 | — | — | US | disclosed |
| US-20100267716-A1 | METHODS OF TREATING INFLAMMATIONS AND INFECTIONS WITH PYRIDINIUM SALTS | KLEIN RICHARD B | 2010-10-21 | — | — | US | disclosed |
| US-20070213299-A1 | COMPOUNDS AND METHODS FOR CONTROLLING FUNGI, BACTERIA AND INSECTS | MYCOSOL, INC. | 2007-09-13 | — | — | US | disclosed |
| US-7220761-B2 | Compounds and methods for controlling fungi, bacteria and insects | MYCOSOL, INC. (US) | 2007-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213299-A1 | COMPOUNDS AND METHODS FOR CONTROLLING FUNGI, BACTERIA AND INSECTS | BLVRB, PNPO, PLPBP | CYP1A2 1498/4885CYP1A1 1805/4885CYP1B1 1069/4885 |
| US-20100267716-A1 | METHODS OF TREATING INFLAMMATIONS AND INFECTIONS WITH PYRIDINIUM SALTS | PNPO, PLPBP, TPMT | CYP1A2 821/4885CYP1A1 1400/4885CYP1B1 1410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.